← Back to ALDX

Aldeyra Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 14/05/2025
−$5.5−$3.5−$7.7−$9.8−$9.9−$15−$17−$8.1
−$0.09−$0.06−$0.13−$0.16−$0.17−$0.25−$0.28−$0.14
6060606060605959

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.